Comprehensive clinical trial delivery across Phase I–III with a focus on quality and efficiency.
Arthur has over 30 years of experience in pharmaceutical industry of which more than 25 years as a Senior Consultant for the non-clinical development of drug candidates, either small molecules or biologics and vaccines.
His experience is in designing the package of non-clinical studies to be performed for starting clinical studies and beyond up to registration, based on OECD, ICH and FDA guidelines, as well as consulting on the set-up of the studies (protocols) and monitoring at contract labs where studies are actually performed.
He has a vast experience in writing (non-clinical parts of) briefing books, Investigator Brochures and IND-modules (eCTD format). Furthermore, he is acting as consultant and principal investigator for pharmacokinetic and toxicokinetic studies, either as stand-alone studies or as part of toxicology studies, both non-GLP and GLP. He obtained a MSc in Pharmacy and a PhD in pharmacology/pharmacokinetics from Leiden University and a PharmD from Utrecht University.
No articles found for this topic.
